期刊文献+

经皮冠状动脉介入术后九例死亡病例分析 被引量:1

The nine cases of percutaneous coronary intervention in patients after analysis of the death cases
下载PDF
导出
摘要 目的分析PCI术后死亡的危险因素及死亡原因。方法我院235例完成PCI术的患者术后共有9例死亡,对32项临床因素进行单因素分析,并对有统计意义的因素进行logistic回归分析。结果单因素分析显示有年龄≥75岁、高血压病史、中风病史、急性非ST段抬高心肌梗死(NSTEMI)、肾小球滤过率(eGFR)<30ml/min/1.72m2、左主干病变(P分别为0.019、0.005、0.005、0.001、0.000、0.047)等6种情况的患者PCI术后死亡率较高,logistic分析显示NSTEMI、eGFR<30ml/min/1.72m2、左主干病变(P分别为0.005、0.017、0.026)等3项则是PCI术后死亡的独立危险因素,死亡原因以心源性原因为主,其中支架内血栓形成或可能的支架内血栓形成是最主要原因。结论 NSTEMI、eGFR<30ml/min/1.72m2、左主干病变等是PCI术后死亡的独立危险因素,支架内血栓形成或可能的支架内血栓形成是最主要死亡原因。 Objective To analysis risk factor and reason of death after PCI.Methods There are 9 cases died in 235 cases who accepted PCI.On one-factor analysis of variance to 32 clinical factor,and proceed logistic regression analysis to the statistically significant factors.Results One-factor analysis of variance show that 6 factors including age≥75,history of hypertension,history of stroke,NSTEMI,eGFR30ml/min/1.72m2 and left main disease are related to death after PCI(P are 0.019、0.005、0.005、0.001、0.000、0.047).Logistic regression analysis show that NSTEMI,eGFR30ml/min/1.72m2 and left main disease are independent risk factors of death after PCI(P are 0.005、0.017、0.026).Cardiac cause is the main cause of death.Stent thrombosis or possible stent thrombosis is the main cause.Conclusion NSTEMI,eGFR30ml/min/1.72m2 and left main disease are independent risk factors of death after PCI.Stent thrombosis or possible stent thrombosis is the main cause of death after PCI.
出处 《实用心脑肺血管病杂志》 2012年第2期211-213,共3页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 血管成形术 经腔 经皮冠状动脉 死亡 LOGISTIC回归分析 Angioplasty transluminal percutaneous coronary Death Logistic regression analysis
  • 相关文献

参考文献7

  • 1陈顺华,刘小慧,康俊萍,吕强,刘新民,聂绍平,吴嘉惠,张崟,贾长琪,陈方,吕树铮,顾承雄,黄方炯,马长生,吴学思.冠心病患者经皮冠状动脉介入治疗死亡率的性别差异[J].中国介入心脏病学杂志,2007,15(6):325-328. 被引量:11
  • 2刘震宇,张抒扬,沈珠军,范中杰,方全,朱文玲.急性心肌梗死患者直接经皮冠状动脉介入术后院内死亡的预测因素[J].中华老年心脑血管病杂志,2008,10(2):87-89. 被引量:5
  • 3Halkin A,Singh M,Nikolsky E,et al.Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction:the CADILLAC risk score[J].J Am Coll Cardiol,2005,45(15):1397-1405.
  • 4高展,杨跃进,陈纪林,乔树宾,徐波,吴永建,袁晋青,陈珏,高润霖.冠状动脉介入治疗术后死亡患者的临床特点[J].中华老年心脑血管病杂志,2008,10(12):905-907. 被引量:6
  • 5Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence,predicttors,and outcome of thrombosis after successful implantationof drug-eluting stents[J].JAMA,2005,293:2126-2130.
  • 6Moreno R,Fernandez C,Hernandez R,et al.Drug-eluting stent t hrombosis:results from a pooled analysis including 10 randomized studies[J].J Am Coll Cardiol,2005,45:954-959.
  • 7Kuchulakanti PK,Chu WW,Torguson R,et al.Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus and paclitaxel-eluting stents[J].Circulation,2006,113:1108-1113.

二级参考文献36

  • 1Sidney CS,James TD, Alice K J, et al. ACC/AHA guidelines for percutaneous coronary intervention. J Am Coll Cardiol, 2001,37:2215-2238.
  • 2Cutlip DE, Windecker S, Mehran M ;et al. Clinical end point in coronary stent trials: a case for standard:ized definitions. Circulation, 2007,115 : 2344-2351.
  • 3Stong GW, Moses JW, Ellis O, et al. Safely and efficacy of sirolimus and paelitaxel eluting coronary stems. N Engl J Med, 2007,356 : 998-1008.
  • 4Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow and moderate-release poly- mer-based paclitaxel-eluting stents for coronary artery lesions. Circulation, 2003,108 : 788-794.
  • 5Cavallinil C, Savonitto S, Violini R, et al. Impact of the elevation of biochemical markers of myocardial damage on longterm mortality after percutaneous coronary intervention: resuits of the CK-MB and PCI study. Eur Heart J, 2005,26: 1494-1498.
  • 6Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coil Cardiol, 2005,45 : 1397-1405.
  • 7Zahn R, Vogt A, Zeymer U. In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte. Heart, 2005, 91: 1041-1046.
  • 8Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol, 2005,45 : 954-959.
  • 9Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors,and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA, 2005,293 : 2126-2130.
  • 10Kuchulakantl PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxet-eluting stents. Circulation, 2006,113 : 1108-1113.

共引文献19

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部